As of 2026-09-19, the Relative Valuation of Selecta Biosciences Inc (SELB) is (2.10) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.88 USD, the upside of Selecta Biosciences Inc based on Relative Valuation is -338.6%.
The range of the Relative Valuation is (4.34) - 0.76 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.0x - 23.8x | 21.4x |
| Forward P/E multiples | 23.9x - 30.0x | 27.0x |
| Fair Price | (4.34) - 0.76 | (2.10) |
| Upside | -592.6% - -13.7% | -338.6% |
| Date | P/E |